With 30% of the population already affected and projections soaring to 41.4% by 2050, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)…
Browsing: Thought Leadership
In this episode, Venture Science founding partner Matt Oguz sits down with the founder & CEO of Jona, a trailblazing…
A surge in the use of non-FDA-approved, compounded, and counterfeit versions of diabetes and obesity drugs like semaglutide (Ozempic/Wegovy) and…
A new short-term federal funding bill has locked in a fifth consecutive year of Medicare physician payment cuts, with 2026…
In this special crossover episode with Physicianary, previous Gut Talk guest, Austin Chiang, MD, and Physicianary host, Hansa Bhargava, MD,…
In this discussion, Dr. Peter Buch and Dr. Aasma Shaukat explore the evolving landscape of colon cancer screening. While stool-based…
In his insightful article, Spencer Dorn, MD, explores how nurse practitioners (NPs) and physician associates (PAs) are reshaping American healthcare…
The article discusses the growing movement to deprescribe GLP-1 therapy for obesity due to cost concerns — but warns this…
Anesthesia plays a crucial role in the efficiency and success of ASCs, particularly in gastroenterology procedures.Five GI leaders recently joined…
As the Gut Doctor podcast continues to raise awareness for colorectal cancer, Dr. Parikh interviews Dr. Paul Limburg, MD, who…